Freenome, Inc. Common stock

NASDAQ: FRNM · Healthcare · Biotechnology

PublicHQ New York, NY · New YorkCIK 0001676446Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 48

v0.1 · 5/100 weight · pillars only

↑ workforce scale, market scale · ↓ listing tenure, market scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

378

as of 2026-09-01

Market cap

$120.6M

as of 2026-09-01

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Freenome, Inc. Common stock’s financial profile?

Freenome, Inc. Common stock has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Biomea Fusion, Inc.——enGene Holdings Inc.——Nautilus Biotechnolgy, Inc.——Milestone Pharmaceuticals Inc.——Polaryx Therapeutics, Inc. Common Stock——Cognition Therapeutics, Inc.——

Neighbors

New York →

JPMorgan Chase & Co.$182.4B72B Morgan Stanley$34.3B61C The Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86A Citigroup Inc.$85.2B55C American Express Company$41.3B78B+

Key facts

CEOAaron Elliott

SectorHealthcare

IndustryBiotechnology

HeadquartersNew York, NY

ExchangeNASDAQ: FRNM

Employees378

IPO date2026-07-21

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.